Streetbeat News

Analyst Ratings

AMZN

Over the past 3 months, 38 analysts have published their opinion on Amazon.com (NASDAQ:AMZN) stock. The company has an average price target of $165.34, an increase of 12.55% from the previous average price target of $146.90. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

BABA

Over the past 3 months, 13 analysts have published their opinion on Alibaba Group Holding (NYSE:BABA) stock. The analysts have an average price target of $135.08 versus the current price of Alibaba at $99.21, implying an upside. The average price target has increased by 2.06% over the past month.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

IMCR

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Immunocore Hldgs (NASDAQ:IMCR) and maintained a $90 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:00 pm

CPRX

Over the past 3 months, 5 analysts have given their opinion on Catalyst Pharmaceuticals (NASDAQ:CPRX) stock. The average price target is $24.2, implying an upside from the current price of $15.02. The majority of the ratings are bullish, with 4 out of 5 analysts giving a positive outlook.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

CARM

CARISMA Therapeutics (NASDAQ:CARM) has received positive analyst ratings in the last quarter, with 3 bullish and 2 somewhat bullish ratings. The average price target is $10.6, indicating an upside from the current price of $5.93. This average has increased by 6.0% from the previous target of $10.00.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

FUBO

FuboTV (NYSE:FUBO) has received mostly bullish ratings from analysts in the last quarter, with 3 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for FuboTV has increased by 22.33% from the previous average, now standing at $3.67.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

BABA

Baird analyst Colin Sebastian maintains an Outperform rating on Alibaba Gr Holding (NYSE:BABA) and raises the price target from $115 to $120.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:59 am

CPRX

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Catalyst Pharmaceuticals (NASDAQ:CPRX) and maintained a price target of $24.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 11:59 am

PHAT

HC Wainwright & Co. analyst Matthew Caufield has reiterated a 'Buy' rating on Phathom Pharmaceuticals (NASDAQ:PHAT) and maintained a price target of $28.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 11:58 am

AIT

Baird analyst David Manthey maintains an Outperform rating on Applied Industrial (NYSE:AIT) and raises the price target from $161 to $185.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:58 am